
Unified Global Action
Architecting a Future Without Amyloidosis.
A global strategic monolith, uniting patients representatives, medical experts, and research institutions across continents to accelerate diagnosis and therapeutic breakthroughs.
24
member
associations
worldwide
24
Member Associations
19
Countries
8
Languages
1
Global Mission
Our Strategic Roadmap
Our Missions
A strategic roadmap for global healthcare transformation and patient empowerment.
Uniting Patient Organizations Worldwide
A global network connecting patient organizations across countries to advance awareness, advocacy, education, research, and patient support.
Amplify the patient voice worldwide
Represent the needs and priorities of people living with amyloidosis before policymakers, healthcare authorities, researchers, and industry stakeholders.
Reduce diagnostic delays
Raise awareness among healthcare professionals and the public to promote earlier diagnosis and improve patient outcomes.
Improve access to care and treatment
Working together to promote equitable access to timely diagnosis, specialized care, and treatments for everyone affected by amyloidosis worldwide.
Advance research and innovation
Support scientific initiatives, foster patient participation in research, and help accelerate the development of new therapies.
Strengthen patient organizations
Empower existing patient groups and support the creation of new organizations in underserved regions of the world.
Generate real-world evidence
Produce and leverage international patient data to better understand the impact of amyloidosis and inform healthcare policies, research priorities, and care pathways.
Mobilize global stakeholders
Bring together patients, caregivers, healthcare professionals, researchers, and partners around a shared mission: improving the lives of everyone affected by amyloidosis.
About the Alliance
Discover the Amyloidosis Alliance
Discover the people, partnerships, and shared mission behind the Amyloidosis Alliance, and how together we are building a stronger future for patients worldwide.
Across Borders
International Dimension
Currently operating across 19 countries, the Alliance creates a redundant network of expertise. Each member nation contributes local insights to a global knowledge base, ensuring no patient is left behind regardless of geography.
- Australia
- Austria
- Belgium
- Brazil
- Canada
- Colombia
- France
- Germany
- Ireland
- Israel
- Italy
- Mexico
- Netherlands
- New Zealand
- South Korea
- Spain
- Sweden
- United Kingdom
- United States

Our member
associations are
spread across
19
countries
“Unity is our strongest diagnostic tool. By crossing borders, we eliminate the isolation of rare disease.”
The Amyloidosis Alliance
Clinical Foundation
Understanding Amyloidosis
The Pathology
Protein Misfolding
Amyloidosis is a rare disease that occurs when an abnormal protein, called amyloid, builds up in organs and interferes with their normal function. Over thirty distinct subtypes exist, each requiring its own diagnostic pathway.
Critical Stat
4+
Years is the average time to diagnosis. Our mission is to reduce this to months through global standard protocols.
Scientific Visualization
Amyloid fibril structure

26
October
Awareness Day
World Awareness Campaign
World Amyloidosis Day
Every year on October 26, World Amyloidosis Day brings together patients, caregivers, healthcare professionals, researchers, institutions, and patient organizations to raise awareness of this rare and complex disease.
The campaign highlights the need for faster diagnosis, better access to care, and a stronger international network. As the dedicated campaign site is integrated into the new Amyloidosis Alliance platform, this section becomes the gateway to actions, resources, testimonies, and global campaign materials.
Latest Updates
Latest News
-
ATTR Amyloidosis meeting replay
Watch ATTR Amyloidosis meeting replay, Baveno, Italy The ATTR Amyloidosis meeting replay 2025 held in Baveno, Italy, is now available. This year’s ATTR Meeting took place in Baveno, Italy, bringing together clinicians, researchers,…
-
ATTR Amyloidosis meeting 2025
ATTR Amyloidosis meeting 2025, Baveno, Italy The ATTR Amyloidosis Congress 2025 held in Baveno, Italy, marked a pivotal moment for…
-
World Amyloidosis Day 2025
What Is World Amyloidosis Day 2025? World Amyloidosis Day 2025 will be observed on October 26, 2025, uniting people around the globe…
